78 related articles for article (PubMed ID: 23290868)
21. Coinfection of Leishmania chagasi with Toxoplasma gondii, Feline Immunodeficiency Virus (FIV) and Feline Leukemia Virus (FeLV) in cats from an endemic area of zoonotic visceral leishmaniasis.
Sobrinho LS; Rossi CN; Vides JP; Braga ET; Gomes AA; de Lima VM; Perri SH; Generoso D; Langoni H; Leutenegger C; Biondo AW; Laurenti MD; Marcondes M
Vet Parasitol; 2012 Jun; 187(1-2):302-6. PubMed ID: 22285010
[TBL] [Abstract][Full Text] [Related]
22. Primary and secondary Toxoplasma gondii infection in normal and feline immunodeficiency virus-infected cats.
Lappin MR; George JW; Pedersen NC; Barlough JE; Murphy CJ; Morse LS
J Parasitol; 1996 Oct; 82(5):733-42. PubMed ID: 8885881
[TBL] [Abstract][Full Text] [Related]
23. Adoptive immunotherapy of feline immunodeficiency virus with autologous ex vivo-stimulated lymphoid cells modulates virus and T-cell subsets in blood.
Flynn JN; Pistello M; Isola P; Zaccaro L; Del Santo B; Ricci E; Matteucci D; Bendinelli M
Clin Diagn Lab Immunol; 2005 Jun; 12(6):736-45. PubMed ID: 15939748
[TBL] [Abstract][Full Text] [Related]
24. Early events in the immunopathogenesis of feline retrovirus infections.
Tompkins MB; Nelson PD; English RV; Novotney C
J Am Vet Med Assoc; 1991 Nov; 199(10):1311-5. PubMed ID: 1666073
[TBL] [Abstract][Full Text] [Related]
25. Lentiviral latency in peripheral CD4+ T cells isolated from feline immunodeficiency virus-infected cats during the asymptomatic phase is not associated with hypermethylation of the proviral promoter.
Murphy B; Hillman C; Mok M; Vapniarsky N
Virus Res; 2012 Oct; 169(1):117-26. PubMed ID: 22846918
[TBL] [Abstract][Full Text] [Related]
26. Productive infection of the bone marrow cells in feline immunodeficiency virus infected cats.
Sandy JR; Robinson WF; Bredhauer B; Kyaw-Tanner M; Howlett CR
Arch Virol; 2002 May; 147(5):1053-9. PubMed ID: 12021873
[TBL] [Abstract][Full Text] [Related]
27. Toll-like receptor expression in feline lymphoid tissues.
Ignacio G; Nordone S; Howard KE; Dean GA
Vet Immunol Immunopathol; 2005 Jul; 106(3-4):229-37. PubMed ID: 15963821
[TBL] [Abstract][Full Text] [Related]
28. Regulation of lentivirus neurovirulence by lipopolysaccharide conditioning: suppression of CXCL10 in the brain by IL-10.
Maingat F; Viappiani S; Zhu Y; Vivithanaporn P; Ellestad KK; Holden J; Silva C; Power C
J Immunol; 2010 Feb; 184(3):1566-74. PubMed ID: 20042580
[TBL] [Abstract][Full Text] [Related]
29. In vivo assessment of natural killer cell responses during chronic feline immunodeficiency virus infection.
Simões RD; Howard KE; Dean GA
PLoS One; 2012; 7(5):e37606. PubMed ID: 22701523
[TBL] [Abstract][Full Text] [Related]
30. Elevated interleukin-10-to-interleukin-12 ratio in feline immunodeficiency virus-infected cats predicts loss of type 1 immunity to Toxoplasma gondii.
Levy JK; Ritchey JW; Rottman JB; Davidson MG; Liang YH; Jordan HL; Tompkins WA; Tompkins MB
J Infect Dis; 1998 Aug; 178(2):503-11. PubMed ID: 9697733
[TBL] [Abstract][Full Text] [Related]
31. Dual lentivirus infection potentiates neuroinflammation and neurodegeneration: viral copassage enhances neurovirulence.
Afkhami-Goli A; Liu SH; Zhu Y; Antony JM; Arab H; Power C
J Neurovirol; 2009 Apr; 15(2):139-52. PubMed ID: 19115133
[TBL] [Abstract][Full Text] [Related]
32. Vertical transmission of feline immunodeficiency virus.
O'Neil LL; Burkhard MJ; Diehl LJ; Hoover EA
AIDS Res Hum Retroviruses; 1995 Jan; 11(1):171-82. PubMed ID: 7734190
[TBL] [Abstract][Full Text] [Related]
33. Neurovirulence in feline immunodeficiency virus-infected neonatal cats is viral strain specific and dependent on systemic immune suppression.
Power C; Buist R; Johnston JB; Del Bigio MR; Ni W; Dawood MR; Peeling J
J Virol; 1998 Nov; 72(11):9109-15. PubMed ID: 9765456
[TBL] [Abstract][Full Text] [Related]
34. Effect of FIV infection on lung inflammatory cell populations recovered by bronchoalveolar lavage.
Hawkins EC; Kennedy-Stoskopf S; Levy JK; Meuten DJ; Cullins L; Tompkins WA; Tompkins MB
Vet Immunol Immunopathol; 1996 May; 51(1-2):21-8. PubMed ID: 8797273
[TBL] [Abstract][Full Text] [Related]
35. Prevention of immunodeficiency virus induced CD4+ T-cell depletion by prior infection with a non-pathogenic virus.
Terwee JA; Carlson JK; Sprague WS; Sondgeroth KS; Shropshire SB; Troyer JL; VandeWoude S
Virology; 2008 Jul; 377(1):63-70. PubMed ID: 18499211
[TBL] [Abstract][Full Text] [Related]
36. Immunopathologic changes in the thymus during the acute stage of experimentally induced feline immunodeficiency virus infection in juvenile cats.
Woo JC; Dean GA; Pedersen NC; Moore PF
J Virol; 1997 Nov; 71(11):8632-41. PubMed ID: 9343221
[TBL] [Abstract][Full Text] [Related]
37. A monoclonal antibody which blocks infection with feline immunodeficiency virus identifies a possible non-CD4 receptor.
Hosie MJ; Willett BJ; Dunsford TH; Jarrett O; Neil JC
J Virol; 1993 Mar; 67(3):1667-71. PubMed ID: 7679750
[TBL] [Abstract][Full Text] [Related]
38. The Third International Feline Retrovirus Research Symposium.
Burkhard MJ; Hoover EA
Vaccine; 1997 Feb; 15(2):107-10. PubMed ID: 9173726
[No Abstract] [Full Text] [Related]
39. Changes of glutathione metabolism during feline immunodeficiency virus infection.
Paolicchi A; Tonarelli P; Silva S; Bandecchi P; Malvaldi G
J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Sep; 13(1):94-6. PubMed ID: 8797692
[No Abstract] [Full Text] [Related]
40. Co-infection of Toxoplasma gondii with other pathogens: pathogenicity and chemotherapy in animal models.
Lacroix C; Brun-Pascaud M; Maslo C; Chau F; Romand S; Derouin F
Curr Top Microbiol Immunol; 1996; 219():223-33. PubMed ID: 8791703
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
